Contact
Please use this form to send email to PR contact of this press release:
Vical Announces Initiation of a Phase 2 Trial of Its HSV-2 Therapeutic DNA Vaccine for Genital Herpes
TO:
Please use this form to send email to PR contact of this press release:
Vical Announces Initiation of a Phase 2 Trial of Its HSV-2 Therapeutic DNA Vaccine for Genital Herpes
TO: